Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,913 across all filing types
Latest filing 2026-02-10 Regulatory Filings
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
As per annexure enclosed
Regulatory Filings
2026-02-10 English
Press Release
Interim / Quarterly Report Classification · 92% confidence The document is an official stock exchange filing titled “Outcome of the Board Meeting” dated 10 February 2026, detailing the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. It includes full financial statements (revenue, expenses, profit before tax, PAT, OCI, EPS) and discloses an interim dividend declaration along with record and payment dates. This is a comprehensive quarterly financial report (with substantive data), not merely a brief earnings highlight or a publication notice. Therefore, it should be classified as an Interim/Quarterly Report. 9M 2026
2026-02-10 English
As per annexure enclosed
Regulatory Filings
2026-02-10 English
As per annexure enclosed
Regulatory Filings
2026-02-10 English
Record Date
Interim / Quarterly Report Classification · 88% confidence The document is the official stock exchange filing (to BSE/NSE) of the outcome of a board meeting, including the unaudited financial results for the three and nine months ended December 31, 2025, complete with detailed financial statements (income, expenses, profit, EPS), limited review report note, and declaration of an interim dividend with record and payment dates. It contains substantive financial data rather than just a short summary or announcement. Therefore, it qualifies as an Interim/Quarterly Report rather than merely an earnings release or a publication announcement. 9M 2026
2026-02-10 English
As per annexure enclosed
Regulatory Filings
2026-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.